Patents Assigned to Intergen Company
  • Patent number: 6768000
    Abstract: An oligonucleotide, labeled with a molecular energy transfer trio and containing two sequences capable of hairpin formation, is used in the detection of two targets by irradiation with a single wavelength of light. One of the two sequences contains an energy donor and a first energy acceptor, and the other sequence contains a second energy acceptor. The donor is in close proximity to the second acceptor only if the hairpin is formed, while the donor is always in close proximity to first acceptor. A sample is assayed, using this oligonucleotide in conjunction with another oligonucleotide which contains the donor fluorophore and the quencher, arranged as described above, but which lacks the acceptor fluorophore. The present oligonucleotide and the other oligonucleotide are specific to first and second targets, respectively.
    Type: Grant
    Filed: January 17, 2001
    Date of Patent: July 27, 2004
    Assignee: Intergen Company
    Inventor: Glenn Nardone
  • Patent number: 6319683
    Abstract: A method and composition for quenching formaldehyde fixation of cell and tissue specimens. The composition includes a formaldehyde-reactive agent. The formaldehyde-reactive agent reacts with the formaldehyde to quench the fixation of the cell or tissue specimen. The method involves contacting a formaldehyde fixative solution with the composition.
    Type: Grant
    Filed: April 14, 1997
    Date of Patent: November 20, 2001
    Assignee: Intergen Company
    Inventors: William M. James, Stephen W. Hoag
  • Patent number: 6117635
    Abstract: The present invention provides labeled nucleic acid amplification oligonucleotides, which can be linear or hairpin primers or blocking oligonucleotides. The oligonucleotides of the invention are labeled with donor and/or acceptor moieties of molecular energy transfer pairs. The moieties can be fluorophores, such that fluorescent energy emitted by the donor is absorbed by the acceptor. The acceptor may be a fluorophore that fluoresces at a wavelength different from the donor moiety, or it may be a quencher. The oligonucleotides of the invention are configured so that a donor moiety and an acceptor moiety are incorporated into the amplification product. The invention also provides methods and kits for directly detecting amplification products employing the nucleic acid amplification primers. When labeled linear primers are used, treatment with exonuclease or by using specific temperature eliminates the need for separation of unincorporated primers.
    Type: Grant
    Filed: April 11, 1997
    Date of Patent: September 12, 2000
    Assignee: Intergen Company
    Inventors: Irina A. Nazarenko, Satish K. Bhatnagar, Emily S. Winn-Deen, Robert J. Hohman
  • Patent number: 6090552
    Abstract: The present invention provides labeled nucleic acid amplification oligonucleotides, which can be linear or hairpin primers or blocking oligonucleotides. The oligonucleotides of the invention are labeled with donor and/or acceptor moieties of molecular energy transfer pairs. The moieties can be fluorophores, such that fluorescent energy emitted by the donor is absorbed by the acceptor. The acceptor may be a fluorophore that fluoresces at a wavelength different from the donor moiety, or it may be a quencher. The oligonucleotides of the invention are configured so that a donor moiety and an acceptor moiety are incorporated into the amplification product. The invention also provides methods and kits for directly detecting amplification products employing the nucleic acid amplification primers. When labeled linear primers are used, treatment with exonuclease or by using specific temperature eliminates the need for separation of unincorporated primers.
    Type: Grant
    Filed: July 11, 1997
    Date of Patent: July 18, 2000
    Assignee: Intergen Company
    Inventors: Irina A. Nazarenko, Satish K. Bhatnagar, Emily S. Winn-Deen, Robert J. Hohman
  • Patent number: 6072086
    Abstract: A method and composition for quenching formaldehyde fixation of cell and tissue specimens. The composition includes a formaldehyde-reactive agent. The formaldehyde-reactive agent reacts with the formaldehyde to quench the fixation of the cell or tissue specimen. The method involves contacting a formaldehyde fixative solution with the composition.
    Type: Grant
    Filed: August 20, 1999
    Date of Patent: June 6, 2000
    Assignee: Intergen Company
    Inventors: William M. James, Stephen W. Hoag